In October, 2017 the Food and Drug Administration approved the use of a new vaccine for the prevention of shingles (herpes zoster). The new vaccine is called Shingrix and in early testing appears to be a remarkable improvement over the previous vaccine (Zostravax) which was approved in 2006. Since January, 2018 the new vaccine has…

Read More